Drug Profile
Research programme: chemoprotection - Sound Pharmaceuticals
Alternative Names: Allopurinol/ebselen; Chemoprevention research programme - Sound Pharmaceuticals; Chemoprotection research programme - Sound Pharmaceuticals; Ebselen/allopurinol; Research programme: chemoprevention - Sound Pharmaceuticals; SPI-3005/6Latest Information Update: 30 Nov 2010
Price :
$50
*
At a glance
- Originator Sound Pharmaceuticals
- Class Chemopreventatives; Chemoprotectants; Purines; Small molecules
- Mechanism of Action Glutathione peroxidase stimulants; Xanthine oxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Sensorineural hearing loss
Most Recent Events
- 30 Nov 2010 Discontinued - Preclinical for Sensorineural hearing loss(chemotherapy-induced, prevention) in USA (PO)
- 24 Feb 2004 Preclinical trials in Sensorineural hearing loss(chemotherapy-induced, prevention) in USA (PO)